« previous next »
Pages: [1]

Author Topic: (Abst.) Outcomes of MS patients w/COVID-19 in large veteran cohort  (Read 28 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Outcomes of MS patients w/COVID-19 in large veteran cohort
« on: June 25, 2022, 09:04:49 pm »

The authors declare no conflict of interest and presumably are not in the pay of the drug companies. Their findings show that MS patients taking DMDs were less likely to die of COVID-19 than MS patients not taking DMDs.

From PubMed (June 24, 2022)--"Outcomes of multiple sclerosis patients admitted with COVID-19 in a large veteran cohort":


https://pubmed.ncbi.nlm.nih.gov/35724529/
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
137 Views 		Last post April 23, 2017, 03:47:31 pm
by agate
0 Replies
113 Views 		Last post May 12, 2019, 11:44:22 am
by agate
0 Replies
33 Views 		Last post September 15, 2020, 09:05:44 pm
by agate
0 Replies
57 Views 		Last post December 05, 2020, 03:54:45 pm
by agate
0 Replies
33 Views 		Last post April 30, 2022, 09:47:47 pm
by agate